News &
Notifications

Home 9 Newsroom ( Page 16 )

Newsroom

Here you will find the latest ESG and investor relations news, studies and press releases from cometis AG and our partner PRGN – Public Relations Global Network.
With the capital market panel and the investor relations panel, cometis has been conducting studies on current market events in the areas of capital markets, ESG and investor relations for several years. To this end, cometis surveys experts from the respective departments several times a year on current topics. In this context, cometis evaluates the topics and the concept and is also responsible for conducting the study.

 

Here, you can go directly to the respective years of Investor Relations News:

July 14, 2020 | zooplus AG: Earnings development in the first half-year significantly above expectations – Management Board updates guidance again for the 2020 financial year

July 14, 2020 | zooplus AG: Earnings development in the first half-year significantly above expectations – Management Board updates guidance again for the 2020 financial year

Ad hoc announcement back to the archive   zooplus AG: Management Board again updates sales and earnings guidance for the 2020 financial ...
ESG: The role of companies

ESG: The role of companies

As unsustainable business practices become more visible, environmental, social and governance issues are becoming increasingly important for ...
ESG: What role does the legislator play?

ESG: What role does the legislator play?

It is no secret that not only Germany, but also the EU is resolutely pushing the issue of sustainability as well as demanding and promoting ...
September 10, 2020 | Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine

September 10, 2020 | Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine

Corporate news to the archive Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 ...
9 September 2020 | Dermapharm publishes Half-Year Financial Report 2020 and confirms growth course despite corona pandemic

9 September 2020 | Dermapharm publishes Half-Year Financial Report 2020 and confirms growth course despite corona pandemic

Corporate News back to archive Dermapharm publishes Half-Year Financial Report 2020 and confirms growth course despite corona pandemic ...

CONTACT

Accept Privacy Policy

DIRECTION